In the semaglutide arm, there was no linear or non-linear trend in subsequent MACE risk by the amount of weight loss at week 20
Mounjaro, meanwhile, is still undergoing research, and its precise properties and applications are yet to be fully defined
The most likely causes include fat and muscle loss, hormonal fluctuations, dehydration, and microbiome shifts rather than a direct drug effect
Consumers and their surviving loved ones are filing Ozempic lawsuits to seek compensation for their immense losses
This conversation will almost always cover: Your Main Goals: Is your top priority weight loss, getting your A1c under control, or tackling other metabolic issues
CONFLICT OF INTEREST STATEMENT The authors have no conflicts to declare